Cargando…

New immunopathologic insights into multiple sclerosis

Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of the central nervous system. Although the immune system seems to play an important role in the pathogenesis of disease, target antigens are still uncertain and pathways leading to tissue destruction have not been fully elu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hemmer, Bernhard, Kieseier, Bernd, Cepok, Sabine, Hartung, Hans-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Current Medicine Group 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088761/
https://www.ncbi.nlm.nih.gov/pubmed/12691630
http://dx.doi.org/10.1007/s11910-003-0085-y
_version_ 1783509606334464000
author Hemmer, Bernhard
Kieseier, Bernd
Cepok, Sabine
Hartung, Hans-Peter
author_facet Hemmer, Bernhard
Kieseier, Bernd
Cepok, Sabine
Hartung, Hans-Peter
author_sort Hemmer, Bernhard
collection PubMed
description Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of the central nervous system. Although the immune system seems to play an important role in the pathogenesis of disease, target antigens are still uncertain and pathways leading to tissue destruction have not been fully elucidated. Recent studies have significantly contributed to a better understanding of the disease process and broadened our view on possible scenarios of disease initiation and progression. We review the role of the immune system for the manifestation and evolution of MS and discuss different pathogenetic concepts. We conclude with an outlook on future strategies to identify the cause of MS.
format Online
Article
Text
id pubmed-7088761
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Current Medicine Group
record_format MEDLINE/PubMed
spelling pubmed-70887612020-03-23 New immunopathologic insights into multiple sclerosis Hemmer, Bernhard Kieseier, Bernd Cepok, Sabine Hartung, Hans-Peter Curr Neurol Neurosci Rep Article Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of the central nervous system. Although the immune system seems to play an important role in the pathogenesis of disease, target antigens are still uncertain and pathways leading to tissue destruction have not been fully elucidated. Recent studies have significantly contributed to a better understanding of the disease process and broadened our view on possible scenarios of disease initiation and progression. We review the role of the immune system for the manifestation and evolution of MS and discuss different pathogenetic concepts. We conclude with an outlook on future strategies to identify the cause of MS. Current Medicine Group 2003 /pmc/articles/PMC7088761/ /pubmed/12691630 http://dx.doi.org/10.1007/s11910-003-0085-y Text en © Current Science Inc 2003 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Hemmer, Bernhard
Kieseier, Bernd
Cepok, Sabine
Hartung, Hans-Peter
New immunopathologic insights into multiple sclerosis
title New immunopathologic insights into multiple sclerosis
title_full New immunopathologic insights into multiple sclerosis
title_fullStr New immunopathologic insights into multiple sclerosis
title_full_unstemmed New immunopathologic insights into multiple sclerosis
title_short New immunopathologic insights into multiple sclerosis
title_sort new immunopathologic insights into multiple sclerosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088761/
https://www.ncbi.nlm.nih.gov/pubmed/12691630
http://dx.doi.org/10.1007/s11910-003-0085-y
work_keys_str_mv AT hemmerbernhard newimmunopathologicinsightsintomultiplesclerosis
AT kieseierbernd newimmunopathologicinsightsintomultiplesclerosis
AT cepoksabine newimmunopathologicinsightsintomultiplesclerosis
AT hartunghanspeter newimmunopathologicinsightsintomultiplesclerosis